France > Industry focus > Healthcare and life sciences > Law firm and leading lawyer rankings
Index of tables
Industry focus: healthcare and life sciences
Other recommended firms
- August Debouzy
BCW & Associés
- Baker & McKenzie SCP
- Bird & Bird
- Clifford Chance
- DLA Piper
- Galien Affaires
Ginestié Magellan Paley-Vincent
- Hoyng Rokh Monegier
- Jones Day
K&L Gates LLP
- Lmt Avocats
- Schertenleib, Cabinet
- Gilles Bigot - Winston & Strawn LLP (corporate)
Jonathan Burnham -
HBC Avocats(corporate, R&D)
- Alain Decombe - Dechert LLP (corporate)
- Christophe Hénin - Intuity (competition, litigation)
- Bernard Geneste - CMS (regulatory)
Alain Gorny -
- Jean-Marc Grosperrin - Dentons (corporate)
- Cécile Derycke - Hogan Lovells (Paris) LLP (litigation)
- Jean-Marie Job - De Gaulle Fleurance & Associés (litigation, regulatory)
- Pascale Poupelin - Dentons (litigation, regulatory)
Jacques-Antoine Robert -
Simmons & Simmons LLP(litigation)
- Mélanie Thill-Tayara - Dechert LLP (competition)
- Emmanuelle Trombe - McDermott Will & Emery AARPI
Allen & Overy LLP is ‘top of the game’ in the patent space and provides ‘a very high level of service’. The firm has ‘great knowledge of the pharmaceuticals industry (patent and regulatory)’ and handles the most ground-breaking patent litigation cases. Recent cases include litigation regarding the validity of a second medical use patent and successfully defending a client in one of the first cases in France involving antibodies. The firm also handles regulatory and corporate work. Clients include leading pharmaceuticals manufacturers. Global practice co-head Laëtitia Bénard is ‘very impressive and the must-use lawyer in the life sciences area’ for patent litigation. The ‘very thoughtful’ David Por has ‘good analytical and communicative skills’ in patent litigation. Alexandre Rudoni and counsel Eveline Van Keymeulen are other names to note.
The ‘outstanding’ Dechert LLP shows ‘depth of expertise, great responsiveness to clients’ needs and responds by tailor-made services’. The firm has ‘great industry knowledge’ and ‘understands and adapts very well to constraints of a start-up company’. The practice has a wide client base made up of promising biotech firms and large pharmaceuticals groups. It provides a full range of expertise: M&A and private equity, regulatory and competition, patent and product litigation proficiency. The practice recently advised Medtech on a €13.6m issuance of convertible shares and assisted Echosens with a minority investment into the company by Cathay Capital and OrbiMed. Baxter, GlaxoSmithKline and Merck Sharpe & Dohme are also clients. The practice is jointly headed by patent expert Marianne Schaffner and the ‘incredibly smart and responsive’ Alain Decombe, who shows ‘great market understanding’. Jacques Sivignon and Mélanie Thill-Tayara, Isabelle Marguet, Anne-Charlotte Rivière are other key names in the group; corporate partner Matthieu Grollemund is also recommended.
Dentons is ‘capable of everything’. The firm provides ‘excellent, precise and strategic work’ and is highly available at all times. The practice, which has deep regulatory and M&A expertise, advises many of the world’s largest pharmaceutical laboratories. It recently assisted Servier Monde with the conclusion of a strategic international partnership with GeNeuro. Pfizer and Takeda are also clients. Pascale Poupelin and Jean-Marc Grosperrin head the team, in which Anne-Laure Marcerou and Olivia Guéguen are other strong assets.
Hogan Lovells (Paris) LLP runs one of the market’s most comprehensive practices. In particular, the team has an impressive product liability caseload, where it is trusted by the largest players in pharmaceuticals, biotech and medical devices; it is involved in the market’s largest ongoing cases, including the high-profile PIP and Gardasil disputes. Practice head Cécile Derycke is a top choice. The firm also has strong regulatory expertise in Mikael Salmela, who recently assisted Bristol-Myers Squibb with setting up its immuno-oncology research foundation. Patent litigation is another top field of expertise, where the team regularly handles cross-border cases for clients such as Eli Lilly. Stanislas Roux-Vaillard is the key contact.
McDermott Will & Emery AARPI has great expertise in collaboration agreements between major laboratories. Recent work includes assisting Servier with its strategic collaboration with Pfizer to develop and commercialise Cellectis’ UCART19 leukaemia treatment, as well as acting for Pierre Fabre in its collaboration with Array Biopharma for two novel oncology products. The team also advises biotech companies during fundraisings and works on e-health projects. Practice head Emmanuelle Trombe and Anthony Paronneau are highly recommended.
Sea Avocats has ‘strong pharmaceutical law and product liability expertise’. The ‘highly available’ team handles sensitive cases and also deals with regulatory matters. It advises leading companies in pharmaceuticals and medical devices, including Pierre Fabre Médicament, Sanofi-Pasteur MSD and Medtronic. The practice co-heads are Alain Gorny, who is ‘a great listener and gives concrete answers’, and Diane Bandon-Tourret.
Simmons & Simmons LLP is the go-to-firm for product liability cases. The team is regularly retained by top laboratories and is currently involved in a high-profile case concerning clinical trials. Alexandre Regniault and global practice head Jacques-Antoine Robert are the key contacts. Other notable contributors are tax expert Jean-Luc Cuadrado, of counsel Eric Nigri – who is a public law expert – and Ombline Ancelin, who recently advised on a merger control matter. MSD is a client.
The ‘excellent’ team at CMS has leading regulatory expertise through the ‘impressive’ Bernard Geneste, who ‘knows his field and understands rapidly how issues may be solved’. The team regularly challenges government rulings on drug price reimbursement, while Jean de la Hosseraye handles product liability work. Arnaud Hugot recently advised on several clinic-related transactions such as Medipole Partenaires’ sale of three sites in Paris.
De Gaulle Fleurance & Associés has top regulatory expertise and also is increasingly being retained to advise on e-health projects; IP is another strong area. The firm represents some major laboratories as well as some start-ups and biotech companies. Jean-Marie Job and Cécile Théard-Jallu are the key contacts.
Fieldfisher provides ‘excellent analysis’ for its growing client base, which includes leading pharmaceuticals and other medical manufacturers. The six-lawyer team is consulted on regulatory issues or in the context of French authority (ANSM) controls, as well as handling litigation. The key contacts are Brigitte Daille-Duclos and practice head Olivier Lantrès, who is ‘committed to the commercial success of his clients’ projects’.
Gide Loyrette Nouel A.A.R.P.I. is involved in high-profile domestic and cross-border patent proceedings in the pharmaceuticals industry, including representing Ono Pharmaceuticals and Bristol-Myers Squibb in the French aspects of a patent dispute relating to a revolutionary immuno-oncology treatment. Grégoire Triet, Arnaud Michel, Emmanuel Larere and Raphaëlle Dequiré-Portier are all recommended. The firm also advises a number of biotech companies in financing, corporate transactions and IPOs.
HBC Avocats has ‘a strong reputation in the biotechnology sector’. The ‘always available’ team has great expertise in licensing and R&D for innovator companies. It assisted Valneva with the negotiation of a major R&D agreement with GlaxoSmithKline. Jonathan Burnham has ‘great knowledge of the industry and provides high-quality intellectual property and contract legal support’.
Intuity often assists leading laboratories and medical devices companies with regulatory, litigious and competition issues; product liability is another strong area of expertise. Christophe Hénin and Anne Servoir are highly recommended.
Reed Smith advises several leading US pharmaceuticals and medical devices manufacturers on regulatory and patent issues. IP experts Marina Cousté and François Jonquères have ‘great business acumen’. The IP practice is notably representing Novozymes in a sue-and-countersue patent dispute with DSM. Daniel Kadar is a key contact for regulatory work. The practice also handles litigation through Benoît Charot and Marie Albertini. The firm also advises various biotech companies on their corporate transactions, such as assisting bioMérieux with the acquisition of Applied Maths. Marc Fredj and Isabelle MacElhone are the key contacts.
Viguié Schmidt’s Etienne Gouesse assists leading laboratories in sensitive product liability cases and also handles regulatory and public sector procurement work.
Winston & Strawn LLP is top-end in a specialised niche of representing clinics and alternative healthcare provides, where it provides ‘one-of-a-kind, in-depth knowledge and extensive experience of the healthcare sector’. The ‘high-quality and friendly’ lawyers ‘meet their clients’ demands and anticipate what will need to be done’. The firm advises health institutions, clinics, professional organisations and practitioners. The practice is quite unique in its combination of strong regulatory, M&A and litigation expertise. Mutuelle Nationale des Hospitaliers, Ramsay Générale de Santé and Point Vision are clients. Practice head Gilles Bigot is ‘outstanding: his knowledge of the sector is unmatched and he has excellent judgement’. Also recommended are Jérôme Herbet and of counsel Florence Naudin, who are ‘responsive and experts in their fields’. Anne-Carine Ropars-Furet and Guillaume-Denis Faure are other names to note.